Bellicum Pharmaceuticals Priced, Nasdaq: BLCM

Early-stage biotech developing controllable cancer immunotherapies.

Industry: Health Care

Latest Trade: $13.82 -0.04 (-0.3%)

First Day Return: +25.7%

Return from IPO: -27.1%

Industry: Health Care

Early-stage biotech developing controllable cancer immunotherapies.
more less
IPO News for Bellicum Pharmaceuticals
more
IPO Data
IPO File Date 11/18/2014
Offer Price $19.00
Price Range $15.00 - $17.00
Offer Shares (mm) 7.4
Deal Size ($mm) $140
IPO Data
IPO Date 12/17/2014
Offer Price $19.00
Price Range $15.00 - $17.00
Offer Shares (mm) 7.4
Deal Size ($mm) $140
Underwriters
more
Company Data
Headquarters Houston, TX
Founded 2004
Employees 30
Website www.bellicum.com